These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16939511)

  • 1. Liver transplantation from an identical twin without immunosuppression, with early recurrence of hepatitis C.
    Yoshizawa A; Takada Y; Fujimoto Y; Koshiba T; Haga H; Nabeshima S; Uemoto S
    Am J Transplant; 2006 Nov; 6(11):2812-6. PubMed ID: 16939511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
    Castells L; Esteban JI; Bilbao I; Vargas V; Allende H; Ribera E; Piron M; Sauleda S; Len O; Pahissa A; Esteban R; Guardia J; Margarit C
    Antivir Ther; 2006; 11(8):1061-70. PubMed ID: 17302376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for viral hepatitis in 2015.
    Ferrarese A; Zanetto A; Gambato M; Bortoluzzi I; Nadal E; Germani G; Senzolo M; Burra P; Russo FP
    World J Gastroenterol; 2016 Jan; 22(4):1570-81. PubMed ID: 26819523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for recurrent hepatitis C virus infection after liver transplantation.
    Balbi E; Leal CR; Pacheco-Moreira LF; Pousa FS; Covelo MC; Gonzalez AC; Oliveira PV; Agoglia L; Roma J; Cariús LP; Enne M
    Transplant Proc; 2009 Apr; 41(3):891-4. PubMed ID: 19376381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.
    Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Reed A; Hemming A; Howard R; Van Der Werf W; Lauwers G; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2002 Nov; 8(11):1000-6. PubMed ID: 12424712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options.
    Saab S; Wang V
    J Clin Gastroenterol; 2003 Aug; 37(2):155-63. PubMed ID: 12869888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation.
    Tamè M; Buonfiglioli F; Del Gaudio M; Lisotti A; Cecinato P; Colecchia A; Azzaroli F; D'Errico A; Arena R; Calvanese C; Quarneti C; Ballardini G; Pinna AD; Mazzella G
    World J Gastroenterol; 2013 Aug; 19(32):5278-85. PubMed ID: 23983430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C recurrence after liver transplantation.
    Bhat I; Mukherjee S
    Panminerva Med; 2009 Dec; 51(4):235-47. PubMed ID: 20195234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of low accelerating dose regimen of interferon/ribavirin antiviral therapy in patients with hepatitis C virus recurrence after liver transplantation.
    Su H; Liu Z; Sun Y; Li H; Zhou S; Zhou X; Gao Y; Tang R; Zhang D; Zhang M
    Ann Transplant; 2015 May; 20():263-8. PubMed ID: 25975740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized extension of pegylated interferon plus ribavirin therapy for recurrent hepatitis C genotype 1b after living-donor liver transplantation.
    Ueda Y; Takada Y; Marusawa H; Egawa H; Uemoto S; Chiba T
    Transplantation; 2010 Sep; 90(6):661-5. PubMed ID: 20110853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.
    Burra P; Targhetta S; Pevere S; Boninsegna S; Guido M; Canova D; Brolese A; Masier A; D'Aloiso C; Germani G; Tomat S; Fagiuoli S
    Transplant Proc; 2006 May; 38(4):1127-30. PubMed ID: 16757285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation.
    Nair S; Lipscomb J; Eason J
    Transplantation; 2008 Aug; 86(3):418-22. PubMed ID: 18698245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syngeneic living-donor liver transplantation without the use of immunosuppression.
    Liu LU; Schiano TD; Min AD; Kim-Schluger L; Schwartz ME; Emre S; Fishbein TM; Bodenheimer HC; Miller CM
    Gastroenterology; 2002 Oct; 123(4):1341-5. PubMed ID: 12360494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case report.
    Knapstein J; Wörns MA; Galle PR; Zimmermann T
    J Med Case Rep; 2014 Jul; 8():257. PubMed ID: 25047566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
    Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
    Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term effects of immune suppression on liver transplant recipients with recurrent hepatitis C viral infection.
    Neff GW; delaGarza J; Shire N; Nishida S; O'Brien CB; Safdar K; Madariaga J; Schiff E; Ruiz P
    Transplant Proc; 2004 Dec; 36(10):3065-7. PubMed ID: 15686695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin.
    Perrakis A; Yedibela S; Schuhmann S; Croner R; Schellerer V; Demir R; Hohenberger W; Müller V
    Transplant Proc; 2011 Dec; 43(10):3824-8. PubMed ID: 22172854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.